BioSpace News Archive

Sage Therapeutics, a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, will host “Sage FutureCast: An R&D Portfolio Review” and report clinical progress in select depression, neurology, and neuropsychiatry franchise programs.

Initial Phase 1b data for KSI-301 in Wet AMD, DME, and RVO to be presented

Acceleron Pharma Inc. announced it will host a webcast and conference call on Monday, August 5, 2019 at 5:00 p.m. EDT to discuss its second quarter 2019 operating and financial results.

ArQule, Inc. announced it will report financial results for the second quarter of 2019 before the market opens on Wednesday, August 7, 2019.

The global smart glass market is expected to post a CAGR of over 20% during the period 2019-2023, according to the latest market research report by Technavio.

While many wish for more, 62 percent of Americans still feel guilty about taking time for themselves

The global data center market is expected to post a CAGR of more than 17% during the period 2019-2023, according to the latest market research report by Technavio.

Global Action Follows Notification of Updated Safety Information from the U.S. Food and Drug Administration (FDA)

Management team is scheduled to present at the 39th Annual Canaccord Genuity Growth Conference, and to conduct one-on-one meetings at the BTIG Biotechnology Conference 2019.

IIPR is also providing DionyMed up to US$2 million of capital to make improvements at the property.